Merilog (insulin aspart-szjj) NDC 0024-5928

NDC codes

FDA NDC Directory

Product NDC (as listed)0024-5928Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00024-5928Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0024-5928-05	00024592805	5 SYRINGE in 1 BOX (0024-5928-05) / 3 mL in 1 SYRINGE (0024-5928-00)Marketed from Feb 14, 2025

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Merilog
Generic name (nonproprietary): insulin aspart-szjj
Active ingredients: Insulin aspart — 100 [iU]/mL
Dosage form: Injection, Solution
Route: Intravenous, Subcutaneous
Labeler: Sanofi-Aventis U.S. LLC
Product type: Prescription drug
Marketing category: BLA — Biologics License ApplicationApplication BLA 761325
Marketing start: Feb 14, 2025
Listing expires: Dec 31, 2026
Other FDA classes: Insulin (Chemical structure)
Identifiers: Product ID 0024-5928_cfcdd91c-ec57-416b-959e-0fd59030bcbbSPL ID cfcdd91c-ec57-416b-959e-0fd59030bcbbSPL set ID eee07a52-1102-4d48-9782-26061db175adRxCUI 2705733, 2705739, 2705741, 2705745UNII D933668QVX
Pharmacologic class: Insulin Analog

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N400024592805 followed by a unit qualifier and the quantity

Package 00024-5928-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 7, 2025.

Indications (excerpt from the label)

MERILOG is indicated to improve glycemic control in adults and pediatric patients with diabetes mellitus. MERILOG is rapid acting human insulin analog indicated to improve glycemic control in adults and pediatric patients with diabetes mellitus ( 1 ).

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under BLA 761325

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under BLA 761325
Product	Strength	Form · route	Labeler	Product NDC
Meriloginsulin aspart-szjj	Insulin aspart 100 [iU]/mL	Injection, SolutionIntravenous, Subcutaneous	Sanofi-Aventis U.S. LLC	0024-5927